4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001415889-24-027119
Director sold 782 shares at $33.10 ($25,884)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rhodes Jason P Director | 2024-11-14 | Sale | −583 | $33.10 | $19,297 | 5,697,508 | I |
| Rhodes Jason P Director | 2024-11-14 | Sale | −4 | $33.10 | $132 | 15,962 | I |
| Rhodes Jason P Director | 2024-11-14 | Sale | −123 | $33.10 | $4,071 | 1,458,568 | I |
| Rhodes Jason P Director | 2024-11-14 | Sale | −72 | $33.10 | $2,383 | 847,316 | I |
| Open-market sales · 782 sh · avg $33.10 · $25,884 | |||||||
Loading xslF345X05/form4-11182024_101143.xml…